Fidelity Investments
LYRA

Fidelity Investments’s LYRA THERAPEUTICS INC LYRA Stock Holding History

Fidelity Investments’s Portfolio LYRA Stock Details LYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-406
Closed -$2.68K – 5516
2025
Q3 		$2.68K Sell
406
-1,342
-77% -$9.84K ﹤0.01% 4901
2025
Q2 		$15.7K Buy
1,748
+584
+50% +$4.85K ﹤0.01% 4375
2025
Q1 		$7.35K Sell
1,164
-832
-42% -$7.78K ﹤0.01% 4592
2024
Q4 		$20.6K Buy
1,996
+1,191
+148% +$13.1K ﹤0.01% 4190
2024
Q3 		$10.3K Buy
+805
New +$11.8K ﹤0.01% 4419
2023
Q3 		– Hold
0
– -$45 – 5432
2023
Q2 		– Hold
0
– – – 5035
2023
Q1 		– Sell
-9
Closed -$1.41K – 5425
2022
Q4 		$1.41K Buy
+9
New +$1.78K ﹤0.01% 4588

Other funds holding LYRA

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AGP
Artia Global Partners Miami, Florida $499M AUM 186.05% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.72% 1-Year Est. Return

Fidelity Investments's LYRA Position: Q4 2025 in Review

Fidelity Investments sold out of LYRA THERAPEUTICS INC (LYRA) in Q4 2025, closing a stake of 406 shares — an estimated $2.68K sold.

Fidelity Investments first reported a position in LYRA in Q4 2022 and held it in 6 quarters. The position peaked at $20.6K in Q4 2024. 23 funds tracked by Wall St. Rank hold LYRA as of Q4 2025.

  • Fidelity Investments reported no remaining LYRA THERAPEUTICS INC position as of Q4 2025 after selling out during the quarter.
  • Fidelity Investments sold 406 LYRA THERAPEUTICS INC shares in Q4 2025, an estimated $2.68K.
  • Fidelity Investments first reported a position in LYRA THERAPEUTICS INC in Q4 2022 and held it in 6 quarters.
  • Fidelity Investments's LYRA THERAPEUTICS INC position peaked at $20.6K in Q4 2024.
  • 23 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q4 2025.

Based on Fidelity Investments's 13F filing for Q4 2025, filed 17 Feb 2026.